Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial

Overview of attention for article published in Cardiovascular Drugs and Therapy, February 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 44 followers.

Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial. : https://t.co/oK3HHOwFrc

30 Jan 2019

Reply Repost Favourite

13 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.